Generic Moderate-Release Formulations Are More “Rugged” In Dose Dumping Tests By FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Quality-by-Design principles applied to alcohol-induced dose-dumping formulations suggested at Oct. 25-26 meeting of the Advisory Committee of Pharmaceutical Science.
You may also be interested in...
FDA Requests Expanded Alcohol Warnings For Extended-Release Morphine Kadian
Alpharma's Kadian joins the list of extended-release opioid analgesics for which FDA has requested expanded label warnings regarding alcohol following the withdrawal of Palladone. Alpharma is planning to conduct in vivo bioequivalence studies with Kadian to assess the clinical implication of the in vitro data.
Lipitor Pricing Offsets Loss In Prescription Volume, Pfizer Says
Declines in Lipitor's prescription volume due to the presence of generic simvastatin are being offset by price increases, Pfizer says
Mail-Order Pharmacy Not Necessarily Cheaper To Health Plans, Ohio Finds
Health plans should account for the rise in utilization that occurs with use of mail-order pharmacy when deciding if mail order saves money, Ohio Public Employees Retirement System Director of Healthcare Scott Streator said at the recent Academy of Managed Care Pharmacy Educational Conference in Chicago